✦ LIBER ✦

Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: Analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trials

✍ Scribed by Peter S. Pang; Mihai Gheorghiade; Jamil Dihu; Karl Swedberg; Sadiya Khan; Aldo P. Maggioni; Liliana Grinfeld; Faiez Zannad; John C. Burnett Jr; John Ouyang; James E. Udelson; Marvin A. Konstam

Book ID: 116192456
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 163 KB
Volume: 161
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2011.02.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EVEREST (Efficacy of Vasopressin Antagon

EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan)

📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

Gender Does Not Affect Postdischarge Out

Gender Does Not Affect Postdischarge Outcomes in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan [EVEREST] Trial)

✍ Ami N. Shah; Robert J. Mentz; Mihai Gheorghiade; Mary J. Kwasny; Angela J. Fough 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Continental Differences in Clinical Char

Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure: Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program

✍ John E.A. Blair; Faiez Zannad; Marvin A. Konstam; Thomas Cook; Brian Traver; Joh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 494 KB

Causes of death and rehospitalization in

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program

✍ Christopher M. O'Connor; Alan B. Miller; John E.A. Blair; Marvin A. Konstam; Pat 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Effects of Tolvaptan in Patients Hospita

Effects of Tolvaptan in Patients Hospitalized with Heart Failure and Renal Impairment and Hypotension in the EVEREST Trial

✍ Peter S. Pang; Marvin A. Konstam; Faiez Zannad; Aldo P. Maggioni; Karl Swedberg; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Rationale and Design of the Multicenter,

Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)

✍ Mihai Gheorghiade; Cesare Orlandi; John C. Burnett Jr.; David DeMets; Liliana Gr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 147 KB